Competition between streptococcus pneumoniae strains: Implications for vaccine-induced replacement in colonization and disease

Epidemiology

Volumn 24, Issue 4, 2013, Pages 522-529

  Mehtälä, Juha ^a   Antonio, Martin ^b   Kaltoft, Margit S ^c   O'Brien, Katherine L ^d   Auranen, Kari ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c STATENS SERUM INSTITUT   (Denmark)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

AMERICAN INDIAN; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CHILD; CONTROLLED STUDY; DENMARK; GAMBIA; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STATISTICAL MODEL; STREPTOCOCCUS PNEUMONIAE;

CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; HUMANS; INFANT; LONGITUDINAL STUDIES; MODELS, BIOLOGICAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 84879889202     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e318294be89     Document Type: Article

References (32)

1. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol. 2007;45: 1225-1233.
2. Principi N, Marchisio P, Schito GC, Mannelli S. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J. 1999;18: 517-523.
3. Hill PC, Cheung YB, Akisanya A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis. 2008;46: 807-814.
4. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19: 187-195.
5. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349: 1341-1348.
6. O'Brien KL, Moulton LH, Reid R, et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet. 2003;362: 355-361.
7. Cutts FT, Zaman SM, Enwere G, et al.; Gambian Pneumococcal Vaccine Trial Group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365: 1139-1146.
8. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci U S A. 1997;94: 6571-6576.
9. Eskola J, Kilpi T, Palmu A, et al.; Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344: 403-409.
10. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005;116:e408- e413.
11. Lexau CA, Lynfeld R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294: 2043-2051.
12. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998- 2004. J Infect Dis. 2007;196: 1346-1354.
13. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011;6736: 62225-62228.
14. Lipsitch M, Dykes JK, Johnson SE, et al. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine. 2000;18: 2895-2901.
15. Weinberger DM, Trzciński K, Lu YJ, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 2009;5:e1000476.
16. Dawid S, Roche AM, Weiser JN. The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect Immun. 2007;75: 443-451.
17. Johnsborg O, Eldholm V, Bjørnstad ML, Håvarstein LS. A predatory mechanism dramatically increases the efficiency of lateral gene transfer in Streptococcus pneumoniae and related commensal species. Mol Microbiol. 2008;69: 245-253.
18. Weinberger DM, Dagan R, Givon-Lavi N, Regev-Yochay G, Malley R, Lipsitch M. Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis. 2008;197: 1511-1518.
19. Granat SM, Ollgren J, Herva E, Mia Z, Auranen K, Mäkelä PH. Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage. J Infect Dis. 2009;200: 99-106.
20. Gray BM, Turner ME, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol. 1982;116: 692-703.
21. Syrjänen RK, Auranen KJ, Leino TM, Kilpi TM, Mäkelä PH. Pneumococcal acute otitis media in relation to pneumococcal nasopharyngeal carriage. Pediatr Infect Dis J. 2005;24: 801-806.
22. Melegaro A, Choi Y, Pebody R, Gay N. Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. Am J Epidemiol. 2007;166: 228-235.
23. Lipsitch M, Abdullahi O, D'Amour A, et al. Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Epidemiology. 2012;23: 510-519.
24. Auranen K, Mehtälä J, Tanskanen A, et al. Between-strain competition in acquisition and clearance of pneumococcal carriage - epidemiologic evidence from a longitudinal study of day-care children. Am J Epidemiology. 2010;171: 169-176.
25. O'Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis. 2007;196: 1211-1220.
26. Turner P, Hinds J, Turner C, et al. Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray. J Clin Microbiol. 2011;49: 1784-1789.
27. O'Brien KL, Nohynek H; World Health Organization Pneumococcal Vaccine Trials Carriage Working Group. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003;22:e1-11.
28. Bronsdon M, O'Brien KL, Whitney CG, et al. Detection of multiple serotypes of Streptococcus pneumoniae in nasopharyngeal secretions using an immunoblot method. J Clin Microbiol. 2004;42: 1596-1600.
29. Kaltoft MS, Skov Sørensen UB, Slotved HC, Konradsen HB. An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. J Microbiol Methods. 2008;75: 540-544.
30. Högberg L, Geli P, Ringberg H, et al. Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillinresistant pneumococci. J Clin Microbiol. 2007;45: 948-952.
31. Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. 2006;194: 682-688.
32. Fraser C, Hanage WP, Spratt BG. Neutral microepidemic evolution of bacterial pathogens. Proc Natl Acad Sci U S A. 2005;102: 1968-1973.